Acutus Medical, Inc. (AFIB)

USD 0.03

(6.67%)

Long Term Debt Summary of Acutus Medical, Inc.

  • Acutus Medical, Inc.'s latest annual long term debt in 2023 was 32.65 Million USD , down -15.27% from previous year.
  • Acutus Medical, Inc.'s latest quarterly long term debt in 2024 Q1 was 35.81 Million USD , up 0.46% from previous quarter.
  • Acutus Medical, Inc. reported annual long term debt of 38.53 Million USD in 2022, down -14.37% from previous year.
  • Acutus Medical, Inc. reported annual long term debt of 45 Million USD in 2021, up 12.11% from previous year.
  • Acutus Medical, Inc. reported quarterly long term debt of 27.9 Million USD for 2024 Q2, down -23.4% from previous quarter.
  • Acutus Medical, Inc. reported quarterly long term debt of 38.22 Million USD for 2023 Q3, down -0.23% from previous quarter.

Annual Long Term Debt Chart of Acutus Medical, Inc. (2023 - 2018)

Historical Annual Long Term Debt of Acutus Medical, Inc. (2023 - 2018)

Year Long Term Debt Long Term Debt Growth
2023 32.65 Million USD -15.27%
2022 38.53 Million USD -14.37%
2021 45 Million USD 12.11%
2020 40.14 Million USD -0.38%
2019 40.29 Million USD 176.18%
2018 14.59 Million USD 0.0%

Peer Long Term Debt Comparison of Acutus Medical, Inc.

Name Long Term Debt Long Term Debt Difference
Biotricity, Inc. 10.85 Million USD -200.797%
Cell MedX Corp. - USD -Infinity%
Dynatronics Corporation 3.25 Million USD -902.124%
Nemaura Medical Inc. 3.08 Million USD -957.568%
PetVivo Holdings, Inc. 1.01 Million USD -3111.037%
RetinalGenix Technologies Inc. - USD -Infinity%
Sonendo, Inc. 14.03 Million USD -132.661%
Telesis Bio, Inc. 5.26 Million USD -519.738%
Talis Biomedical Corporation 16.78 Million USD -94.531%
Viveve Medical, Inc. 5.12 Million USD -537.276%